BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35340033)

  • 1. Using a structural vulnerability framework to understand the impact of COVID-19 on the lives of Medicaid beneficiaries receiving substance use treatment in New York City.
    Zhen-Duan J; Gade N; Falgas-Bagué I; Sue KL; DeJonckheere M; Alegría M
    Health Serv Res; 2022 Oct; 57(5):1104-1111. PubMed ID: 35340033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "At Home, with Care": Lessons from New York City Home-based Primary Care Practices Managing COVID-19.
    Franzosa E; Gorbenko K; Brody AA; Leff B; Ritchie CS; Kinosian B; Ornstein KA; Federman AD
    J Am Geriatr Soc; 2021 Feb; 69(2):300-306. PubMed ID: 33179761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges with social distancing during the COVID-19 pandemic among Hispanics in New York City: a qualitative study.
    Gonzalez CJ; Aristega Almeida B; Corpuz GS; Mora HA; Aladesuru O; Shapiro MF; Sterling MR
    BMC Public Health; 2021 Oct; 21(1):1946. PubMed ID: 34702228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/Ethnic Disparities in Substance Use Treatment in Medicaid Managed Care in New York City: The Role of Plan and Geography.
    Alegría M; Falgas-Bague I; Fukuda M; Zhen-Duan J; Weaver C; O'Malley I; Layton T; Wallace J; Zhang L; Markle S; Lincourt P; Hussain S; Lewis-Fernández R; John DA; McGuire T
    Med Care; 2022 Nov; 60(11):806-812. PubMed ID: 36038524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences of Home Health Care Workers in New York City During the Coronavirus Disease 2019 Pandemic: A Qualitative Analysis.
    Sterling MR; Tseng E; Poon A; Cho J; Avgar AC; Kern LM; Ankuda CK; Dell N
    JAMA Intern Med; 2020 Nov; 180(11):1453-1459. PubMed ID: 32749450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telehealth Uptake into Prenatal Care and Provider Attitudes during the COVID-19 Pandemic in New York City: A Quantitative and Qualitative Analysis.
    Madden N; Emeruwa UN; Friedman AM; Aubey JJ; Aziz A; Baptiste CD; Coletta JM; D'Alton ME; Fuchs KM; Goffman D; Gyamfi-Bannerman C; Kondragunta S; Krenitsky N; Miller RS; Nhan-Chang CL; Saint Jean AM; Shukla HP; Simpson LL; Spiegel ES; Yates HS; Zork N; Ona S
    Am J Perinatol; 2020 Aug; 37(10):1005-1014. PubMed ID: 32516816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic.
    Hughes PM; Easterly CW; Thomas KC; Shea CM; Domino ME
    J Addict Med; 2024 Mar-Apr 01; 18(2):e1-e7. PubMed ID: 38345239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City.
    Allen B; Basaraba C; Corbeil T; Rivera BD; Levin FR; Martinez DM; Schultebraucks K; Henry BF; Pincus HA; Arout C; Krawczyk N
    Prev Med; 2023 Jul; 172():107533. PubMed ID: 37146730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Tale of Two Cities During the COVID-19 Pandemic: Evaluating Food Insecurity in Chicago and New York City.
    Mazzeo J; Al Abdeen Qusair Z; Gadhoke P; Freiberg T; Brenton BP; Sedlacek A; Torres A
    J Racial Ethn Health Disparities; 2023 Aug; 10(4):1703-1720. PubMed ID: 35831703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and disparities in telehealth use among Louisiana Medicaid beneficiaries with type 2 diabetes.
    Shao Y; Shi L; Nauman E; Price-Haywood E; Stoecker C
    Diabetes Obes Metab; 2023 Sep; 25(9):2680-2688. PubMed ID: 37340211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
    Galarneau LR; Hilburt J; O'Neill ZR; Buxton JA; Scheuermeyer FX; Dong K; Kaczorowski J; Orkin AM; Barbic SP; Bath M; Moe J; Miles I; Tobin D; Grier S; Garrod E; Kestler A
    PLoS One; 2021; 16(7):e0255396. PubMed ID: 34324589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic.
    Tilhou AS; Dague L; Saloner B; Beemon D; Burns M
    JAMA Health Forum; 2022 Mar; 3(3):e220093. PubMed ID: 35977284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID-19 pandemic among low-income women in New York City.
    Chen YS; Zhou ZN; Glynn SM; Frey MK; Balogun OD; Kanis M; Holcomb K; Gorelick C; Thomas C; Christos PJ; Chapman-Davis E
    Cancer; 2021 Jul; 127(14):2399-2408. PubMed ID: 33899220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not a New Story: Place- and Race-Based Disparities in COVID-19 and Influenza Hospitalizations among Medicaid-Insured Adults in New York City.
    Howland RE; Wang S; Ellen IG; Glied S
    J Urban Health; 2022 Apr; 99(2):345-358. PubMed ID: 35192184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post-COVID Era.
    Chang JE; Lai AY; Gupta A; Nguyen AM; Berry CA; Shelley DR
    Milbank Q; 2021 Jun; 99(2):340-368. PubMed ID: 34075622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of COVID-19 on residential treatment programs for substance use disorder.
    Pagano A; Hosakote S; Kapiteni K; Straus ER; Wong J; Guydish JR
    J Subst Abuse Treat; 2021 Apr; 123():108255. PubMed ID: 33375986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review.
    Adams A; Blawatt S; MacDonald S; Finnick R; Lajeunesse J; Harrison S; Byres D; Schechter MT; Oviedo-Joekes E
    Int J Drug Policy; 2023 Jul; 117():104058. PubMed ID: 37182352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Returning home during the pandemic: a thematic analysis describing experiences of people with substance use disorders released early from New Jersey prisons during COVID-19.
    Bono MH; Treitler P; Saloner B; Crystal S
    Health Justice; 2023 Feb; 11(1):11. PubMed ID: 36847934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Qualitative Study of Health Workers' Experiences During Early Surges in the COVID-19 Pandemic in the U.S.: Implications for Ongoing Occupational Health Challenges.
    Goff SL; Wallace K; Putnam N; Fernandes M; Chow E; DaCosta M; Clary K
    Front Public Health; 2022; 10():780711. PubMed ID: 35392468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.